U.S. Embassy in Cameroon

U.S. Embassy in Cameroon


On the occasion of the World Pharmacists Day under this year’s theme, “Pharmacy: Always Trusted for Your Health,” the U.S. government, through the United States Agency for International Development (USAID), donated health and safety equipment to the Regional Fund for the Promotion of Health in Douala to strengthen the supply chain and increase availability of safe medicines and essential commodities for health facilities in the Littoral region.

USAID/Cameroon’s Country Representative Paul Richardson said: “The United States government provides support to Cameroon’s 10 Regional Funds for the Promotion of Health to establish and implement a last-mile distribution strategy to deliver lifesaving medicines to about 350,000 HIV/AIDS patients.  With an investment of about 38 billion CFA (USD$68 million) since 2011, we have provided technical assistance, logistics support, minor infrastructure upgrades, and the procurement of HIV/AIDS and malaria commodities for Cameroon, as well as supported the shipment of 303,050 doses of COVID-19 vaccines to Cameroon through the COVAX mechanism.”

USAID donated a generator, computer equipment, smoke detectors, and fire extinguishers, aimed at improving last-mile delivery operations, warehouse storage conditions, and inventory management of health commodities.  Cameroonian officials in attendance included Regional Delegate of Public Health in the Littoral Region Dr. Albert Mambo, Director of Pharmacy, Medicines and Laboratories Dr. Sadou Salihou, Administrator of the Regional Fund for Health Promotion Dr. Joseph Marie Bikoti, Coordinator of the Regional Technical Group Dr. Victorinne Noelle Nicole Yongu, and President of Cameroon’s National Order of Pharmacists Dr. Franck Nana.

The U.S. Embassy looks forward to strengthening collaboration with the Cameroon Ministry of Public Health to improve health conditions for all Cameroonians.

Distributed by APO Group on behalf of U.S. Embassy in Cameroon.

Send us your press releases to pressrelease.zawya@refinitiv.com


© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.